Evidence map›Paper›PMID 42294709›Full record

ArticleMicrobiology spectrum2026

Genome-based re-evaluation of the ECA75F sequence and development of a dual-probe real-time PCR assay for differentiating

Junko Isobe, Tetsuya Harada, Emi Maenishi, Kazuki Saito, Keiko Kimata, Jun-Ichi Kanatani, Kazunori Oishi, Sunao Iyoda, Masanori Watahiki

Abstract readEvaluation Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Junko IsobeDepartment of Bacteriology, Toyama Institute of Health, Imizu, Toyama, Japan.
Tetsuya Harada *Division of Microbiology, Osaka Institute of Public Health, Osaka-City, Osaka, Japan.ORCID 0000-0001-8757-1436
Emi MaenishiDepartment of Bacteriology, Toyama Institute of Health, Imizu, Toyama, Japan.
Kazuki SaitoDepartment of Bacteriology, Toyama Institute of Health, Imizu, Toyama, Japan.
Keiko KimataDepartment of Bacteriology, Toyama Institute of Health, Imizu, Toyama, Japan.ORCID 0009-0006-8468-2329
Jun-Ichi KanataniDepartment of Bacteriology, Toyama Institute of Health, Imizu, Toyama, Japan.
Kazunori OishiDepartment of Bacteriology, Toyama Institute of Health, Imizu, Toyama, Japan.
Sunao IyodaDepartment of Bacteriology I, National Institute of Infectious Diseases, Shinjuku, Tokyo, Japan.
Masanori Watahiki *Department of Bacteriology, Toyama Institute of Health, Imizu, Toyama, Japan.ORCID 0009-0003-8191-2553

Funding

Research Program on Emerging and Re-emerging Infectious Diseases from the Japan Agency for Medical Research and Development (AMED) 24fk0108702j0001, 25fk0108702h0002, 26fk0108702h0003
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Dysentery, BacillaryEscherichia coliEscherichia coli InfectionsReal-Time Polymerase Chain ReactionShigellaDNA, BacterialGenome, BacterialHumansMultilocus Sequence TypingPhylogenyRNA, Ribosomal, 16SSensitivity and SpecificityDNA, BacterialRNA, Ribosomal, 16Sdual-probe real-time polymerase chain reactionECA75F sequenceenteroinvasive Escherichia colimultilocus sequence typingShigella species

Identifiers

PMID42294709
PMCPMC13340235

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.